April 19, 2014

Congressman Posey Introduces Bill Requiring Study of Autism Rate in Vaccinated vs. Unvaccinated

Has the CDC done a study on vaccinated vs unvaccinated children Congressman Posey Introduces Bill Requiring Study of Autism Rate in Vaccinated vs. Unvaccinated

Health Impact News Editor Comments

Congressman Posey won lots of applause from the autism community late last year during the Congressional hearing on autism. He grilled Dr. Boyle of the CDC on the issue of why there had never been a study conducted comparing vaccinated and unvaccinated children. He was also highly critical of the CDC’s use of public funds in studying the issue, and the fraud of Dr. Poul Thorsen over grant money.

The Refusers is now reporting that Congressman Posey is taking the further step of introducing a bill requiring the study of vaccinated versus unvaccinated children. It is H.R. 1757, and Representative Carolyn Maloney is a co-sponsor at this point. I encourage everyone to contact their representative in Congress and have them co-sponsor and support this bill:

To direct the Secretary of Health and Human Services to conduct or support a comprehensive study comparing total health outcomes, including risk of autism, in vaccinated populations in the United States with such outcomes in unvaccinated populations in the United States, and for other purposes.

The Autism Action Network has supplied an easy form to use to contact your Representative (scroll to bottom): Take Action

Congressman introduces bill requiring study of autism rate in vaccinated vs. unvaccinated

by Michael Belkin
The Refusers

The CDC has refused to study the autism rate in vaccinated vs. unvaccinated kids, because they are a captive agency of vaccine manufacturers. The former head of the CDC is now the head of Merck vaccines, the largest US vaccine manufacturer. CDC officials have been disrespectful, bumbling fools when required to testify before Congress.

The CDC is reluctant to compare autism rates in unvaxed vs. vaxed because it will likely show the same thing as the following study and survey, a huge increase in autism risk in the vaccinated. Of course such data will indict the CDC and expose their responsibility for creating the biggest epidemic in US history: Vaccine-induced autism.

Continue Reading the Article Here: http://therefusers.com/refusers-newsroom/congressman-introduces-bill-requiring-study-of-autism-rate-in-vaccinated-vs-unvaccinated/#.UYAbkj4idok

HON. Bill Posey
Of Florida
IN THE HOUSE OF REPRESENTATIVES
Friday, April 26, 2013

I rise today to draw the attention of the Congress and the American people to the Autism epidemic that is tragically ravaging too many of America’s children.

April is Autism Awareness Month, and I am pleased to join with parents, siblings, grandparents, special education school teachers, medical care providers, and interventionists to draw attention to the rapidly expanding autism community.

When I was young, autism was virtually unheard of. In the 1980s rarely did you meet someone who knew someone with autism. Yet, in the 1990s there was an explosion of autism. Indeed, in the course of just my lifetime, Autism Spectrum Disorder has grown from a very rare condition to – according to the Centers for Disease Control – a developmental disorder affecting 1-in-50 school aged children. And, tragically, the rate for school aged boys is a disturbing 1-in-33.

On December 19, 2006, the effort to address this epidemic took a major step forward as President Bush signed into law the bipartisan Combating Autism Act. I look forward to working with my colleagues and the Autism community to reauthorize this program next year. Though the Interagency Autism Coordinating Committee each year produces a strategic plan to address Autism, the billion-dollar allocation of resources to autism has not been evenly invested among genetic, epigenetic, and environmental factors. I must concur with the experts who have been willing to speak out, that the epidemic increase in the rates of autism are not a ‘genetic’ epidemic. Indeed, you don’t have genetic epidemics. While there is likely a genetic component to many who have been diagnosed with Autism, we must seriously consider that there are likely several key factors in autism.

Also, so some who have suggested that the increase in Autism is due to better diagnosis, you don’t go from 1 in 1,000 to 1 in 80 in three decades due to better diagnosis alone. And, if that were the case, where are the tens of thousands of autistic adults in their 40s, 50s and 60s. While better diagnosis may be a factor, common sense says there is a real increase and something is causing it.

While some may be borne with Autism, there are many parents who testify to the fact and present cases where their children were progressing normally but something triggered a regression where they lost speech, abilities, and regressed from developmental milestones that they had earlier met. Was that regression due to external factors such as medical injury, exposure to environmental toxins such as lead or mercury, or was it adverse reactions to medications that lead to high fevers, brain inflammation or seizures? We must get answers to these questions.

I was pleased to participate in a November 2012 House Oversight and Government Reform hearing on the Federal Response to Autism. That was one of the most attended hearings I have participated in since coming to Washington in 2009. Indeed at this hearing it was standing room only, and overflow rooms had to be used to accommodate the public. This was a much anticipated hearing from many parents of children suffering from Autism who want clear and unbiased answers to questions surrounding the epidemic.
I, like many in Congress, were frustrated with the lackluster response from the federal witnesses, particularly the CDC witness that was evasive and took more than five months to respond to the Committee’s questions. The responses that finally arrived this month were incomplete, often evasive, and showed a complete lack of urgency on the part of the CDC. I was also disappointed that the federal government witnesses did not have the courtesy to remain at the hearing to listen to the testimony of the public panel representing non-profit organizations and academic institutions focused on Autism and Asperger’s Syndrome.

Parents, grandparents, educators, health professionals, and highly functional adults on the autism spectrum are frustrated at the federal response to this epidemic. There is much more that we could and should be doing.

Some believe that toxins like thimerosal, which is 50% ethylmercury, have played a role in the rise in autism and neurodevelopmental disabilities. In 2000 there was near universal agreement that mercury should be removed as a preservative for vaccines. Yet, today, nearly half of all annual flu vaccines, which are recommended for children and pregnant women, still contain mercury as a preservative – not simply trace amounts of mercury. It’s 2013! Why are we still injecting ethylmercury into babies and pregnant women?

I have been deeply disappointed in the failure of the CDC and the Department of Justice to see that Dr. Poul Thorsen is extradited to the United States to stand trial for orchestrating an elaborate scheme stealing more than $1 million from the CDC-Denmark grant. That money was supposed to be used to investigate the causes of autism and developmental disabilities. Instead it was diverted to personal use by Dr. Thorsen. Thorsen was a key author on 22 of the CDC’s key studies related to autism and developmental disabilities.

Before coming to Congress in 2009, I heard from some in the autism community who have advocated for a retrospective study to examine whether there are different health outcomes when comparing vaccinated children and unvaccinated children, including autism and chronic conditions. I have continued to hear these requests over the past four years. At the hearing I asked CDC if they had conducted such a study and they said they’ve done dozens of studies related to autism but never have looked at a comparison of vaccinated versus unvaccinated. In fact, a recent study they published compared fully vaccinated children to those who were not fully vaccinated, but for some reason it did not include data on completely unvaccinated children. Seems like common sense to do a study comparing vaccinated children vs unvaccinated and this week I was pleased to be joined by my colleague Rep. Carolyn Maloney (D-NY) in introducing H.R. 1757, The Vaccine Safety Study Act. This would direct the National Institutes of Health to conduct a retrospective study of health outcomes, including autism, of vaccinated versus unvaccinated children. That should bring an answer to this decades long question.

Whether the number is 1-in-88 twelve-year-olds, or 1-in-50 school-aged children, or 1-in-33 young boys, we can all agree that the number is devastatingly high. We must overturn every stone to get to the bottom of this epidemic. We cannot afford to see this epidemic grow. We must examine every possible risk factor to protect the world’s greatest resource: our children. And, we must invest to develop the best interventions to help those who are autistic.

Vaccine Epidemic
by Louise Kuo Habakus and Mary Holland J.D.

Vaccine Epidemic bookcover Congressman Posey Introduces Bill Requiring Study of Autism Rate in Vaccinated vs. Unvaccinated

FREE Shipping Available!

More Info

0 commentsback to post

Other articlesgo to homepage

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

Congressman Bill Posey’s strong resolve and demands for transparency were evident as he discussed the Center for Disease Control (CDC)’s handling of vaccine safety studies which affect “our most precious resource in our nation – our children.” The 30-minute interview, conducted by vaccine industry watchdog, PhD biochemist Brian Hooker, delves into what Posey called “the incestuous relationship between the public health community and the vaccine makers and public officials.”

The Florida legislator, known as “Mr. Accountabililty,” did not mince words when criticizing current and past CDC officials including indicted fraudster Dr. Poul Thorsen; CDC director turned Merck Vaccine President Dr. Julie Gerberding; and the agency’s current spokesperson regarding autism and vaccines, Dr. Coleen Boyle.

Congressman Posey said, “The CDC can’t be trusted regarding investigating vaccine safety. Huge conflict of interest. I think the CDC should be investigated.”

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

In an interview with Dr. Bernard Dalbergue, a former pharmaceutical industry physician with Gardasil manufacturer Merck, he predicts that Gardasil will become the greatest medical scandal of all time. Dr. Dalbergue believes that at some point in time, the evidence will add up to prove that this vaccine, technical and scientific feat that it may be, has absolutely no effect on cervical cancer and that all the very many adverse effects which destroy lives and even kill young girls, serves no other purpose than to generate profit for the manufacturers.

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

An important new book by a recognized medical research expert describes Big Pharma as akin to the Mafia. In an interview conducted by our colleagues at ANH-Europe, Dr. Peter C. Gøtzsche exposes the flaws of the drug approval system, our reliance on dangerous drugs, and the deadly co-dependence between regulators and industry. Dr. Gøtzsche is co-founder of the highly respected Cochrane Collaboration and Cochrane Reviews, a leading journal of evidence-based medicine. The interview is particularly timely now that the FDA has decided to remove restrictions on the dangerous drug Avandia.

Dr. Gøtzsche’s new book, Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare, points out that the pharmaceutical industry is allowed to test their own drugs, and thus effectively be their own judge. He calls this a threat to safe medicine and asks for open access to all research data, including raw data, because otherwise, data can be easily suppressed and conclusions manipulated by industry.

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical marijuana, or cannabis, is legal in 20 US states, where it is used for a variety of medical conditions such as mood disorders, pain disorders, multiple sclerosis, and even cancer. Parents of children with epilepsy met at a news conference to share their dismay that Governor Mark Dayton refuses to legalize medical marijuana. About 85 percent to 95 percent of Americans are in favor of medical cannabis, and nearly 60 percent are in favor of legalizing marijuana. Cannabis shows outstanding promise as a medicinal plant, largely due to its cannabidiol (CBD) content. Cannabinoids interact with your body by way of naturally occurring cannabinoid receptors embedded in cell membranes throughout your body.

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Pharmaceutical company payments to doctors extend far beyond rank-and-file clinicians — and deep into the leadership of America’s teaching hospitals, according to a study published recently in the Journal of the American Medical Association.

A team of researchers at the University of Pittsburgh Medical Center examined the boards of the 50 largest drug companies by global sales (excluding three companies that were not publicly traded). The researchers found that 40 percent — 19 companies — had at least one board member who also held a leadership role at an academic medical center. Sixteen of the 17 companies based in the United States had at least one. Several had more than one. All told, the research team found that 41 of the companies’ 2012 board members held leadership positions at academic medical centers. Six of the 41 were pharmaceutical company executives who served on hospital boards of directors or held other leadership posts.

The authors wrote that when academic medical leaders serve on pharmaceutical company boards, it can lead to conflicts not only for individuals, but for the critically important health care institutions they guide.

read more


Get the news right in your inbox!